RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A Matching Adjusted Indirect Comparison Of Sonidegib And Vismodegib In Advanced Basal Cell Carcinoma
Odom, D., Mladsi, D., Purser, M., Kaye, J., Palaka, E., Charter, A., Jensen, J., & Sellami, D. (2016). A Matching Adjusted Indirect Comparison Of Sonidegib And Vismodegib In Advanced Basal Cell Carcinoma. Value in Health, 19(3), A122-A122. https://doi.org/10.1016/j.jval.2016.03.492
The comparative effectiveness of sonidegib vs vismodegib remains unchanged after adjusting BOLT patient-level data to match published ERIVANCE values for baseline prevalence of prior surgery and radiotherapy.
